» Articles » PMID: 2167763

Inhibition of the Amorphous Calcium Phosphate Phase Transformation Reaction by Polyphosphates and Metal Ions

Overview
Specialty Pathology
Date 1990 Aug 1
PMID 2167763
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The induction time for amorphous calcium phosphate (ACP) phase transformation was monitored at pH 7.4 and T = 25 degrees C with [Ca2+]o = [PO4]o = 4.0 X 10(-3) M, as a function of added crystal growth inhibitors Mg2+, Sr2+, Zn2+, pyrophosphate (PP), and tripolyphosphate (TPP). Metal ions increase the induction time for the initiation of the phase change reaction in the order Zn2+ less than Sr2+ less than Mg2+. For polyphosphates it was observed that both PP and TPP are potent inhibitors with TPP more effective than PP as expected. The combination of Mg2+ or Sr2+ and PP or TPP leads to a synergistic delay in the onset of the phase conversion. The greatest inhibition was observed for Mg2+ and TPP. Reaction solutions containing 2.0 X 10(-4) M Mg2+ and 4.0 X 10(-5) M TPP resulted in a 90% increase in the induction time over what would be anticipated from an additive effect from these species.

Citing Articles

The application of hydrogels for enamel remineralization.

Liao J, Qiu J, Lin Y, Li Z Heliyon. 2024; 10(13):e33574.

PMID: 39040369 PMC: 11261051. DOI: 10.1016/j.heliyon.2024.e33574.


Incorporating strontium enriched amorphous calcium phosphate granules in collagen/collagen-magnesium-hydroxyapatite osteochondral scaffolds improves subchondral bone repair.

Xu J, Vecstaudza J, Wesdorp M, Labberte M, Kops N, Salerno M Mater Today Bio. 2024; 25:100959.

PMID: 38327976 PMC: 10847994. DOI: 10.1016/j.mtbio.2024.100959.


Ethoxylated bisphenol dimethacrylate-based amorphous calcium phosphate composites.

Skrtic D, Antonucci J, Liu D Acta Biomater. 2006; 2(1):85-94.

PMID: 16701862 PMC: 1839056. DOI: 10.1016/j.actbio.2005.10.004.


Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite.

Qiu S, Wen G, Hirakawa N, Soloway R, Hong N, Crowther R J Clin Invest. 1991; 88(4):1265-71.

PMID: 1655828 PMC: 295595. DOI: 10.1172/JCI115430.


Modulation of bone calcium-binding sites regulates plasma calcium: an hypothesis.

Bronner F, Stein W Calcif Tissue Int. 1992; 50(6):483-9.

PMID: 1525701 DOI: 10.1007/BF00582159.

References
1.
LeGeros R, Kijkowska R, Legeros J . Formation and transformation of octacalcium phosphate, OCP: a preliminary report. Scan Electron Microsc. 1984; (Pt 4):1771-7. View

2.
Termine J, Peckauskas R, Posner A . Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation. Arch Biochem Biophys. 1970; 140(2):318-25. DOI: 10.1016/0003-9861(70)90072-x. View

3.
Williams G, SALLIS J . Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calcif Tissue Int. 1982; 34(2):169-77. DOI: 10.1007/BF02411229. View

4.
Eanes E, Termine J, NYLEN M . An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite. Calcif Tissue Res. 1973; 12(2):143-58. DOI: 10.1007/BF02013730. View

5.
Boulet M, MARIER J, Rose D . Effect of magnesium on formation of calcium phosphate precipitates. Arch Biochem Biophys. 1962; 96:629-36. DOI: 10.1016/0003-9861(62)90348-x. View